CA Stock MarketDetailed Quotes

Apotex Health Corp (APTX)

Watchlist

33.190
-0.680-2.01%

15min DelayMarket Closed Aug 24 16:00 ET

7.58BMarket Cap-278.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apotex Health Corp (APTX) Cash Flow

Quarterly·All

YOY

Hide blank lines

Currency: CAD

2027/Q1

2026/Q1

Operating Cash Flow

-92.79%29.30M

--406.60M

Net cash flow from continuing operations

-92.79%29.30M

--406.60M

Net Income from Continuing Operations

-110.57%-38.35M

--362.70M

Gain/Loss from Continuing Operations

+179.30%28.16M

---35.51M

Depreciation & Depletion & Amortization

+34.87%37.65M

--27.92M

Asset Impairment Expenditure

--5.84M

--0.00

Stock-Based Compensation

+459.78%102.68M

--18.34M

Deferred Tax

-73.91%25.21M

--96.66M

Other Non-Cash Items

-3.12%72.41M

--74.75M

Change in Working Capital

-147.71%-152.85M

---61.71M

-Change in Receivables

+35.23%-109.56M

---169.15M

-Change in Inventory

-116.49%-8.23M

--49.90M

-Change in Payables and Accrued Expense

+272.14%63.24M

---36.74M

-Change in Other Current Assets

-101.69%-3.61M

--213.87M

-Change in Other Current Liabilities

-77.42%-110.00K

---62.00K

-Change In Other Working Capital

+20.87%-94.58M

---119.53M

Interest Paid CFO

-22.59%-43.93M

---35.84M

Tax Refund Paid

+81.54%-7.52M

---40.71M

Net cash flow from investing

-80.01%-61.67M

---34.26M

Net Cash Flow from Continuing Investing Activities

-80.01%-61.67M

---34.26M

Net PPE Purchase and Sale

-92.92%-38.09M

---19.74M

Net Intangibles Purchase and Sale

-62.45%-23.59M

---14.52M

Financing Cash Flow

+516.65%230.99M

---55.44M

Net Cash Flow from Continuing Financing Activities

+516.65%230.99M

---55.44M

Net Issuance Payments Of Debt

-919.81%-565.37M

---55.44M

Net Common Stock Issuance

--850.00M

--0.00

Net Other Financing Charges

---53.64M

----

Ending Cash Balance

-33.67%258.76M

--390.10M

Net Change in Cash

-37.33%198.61M

--316.90M

Beginning Cash Balance

-26.90%56.99M

--77.97M

Effect of Exchange Rate Changes

+166.16%3.15M

---4.77M

Free Cash Flow

-108.69%-32.37M

--372.34M

Deadline

Jun 30, 2026

Jun 30, 2025

Accounting Standard

US_GAAP

	2027/Q1	2026/Q1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.